FPR2 Antikörper (C-Term)

Produktnummer ABIN5540337

Der Kaninchen Polyklonal anti-FPR2 Antikörper wird verwendet zum Nachweis von FPR2 in Proben von Human. Er wurde validiert für WB, IF und ICC.

Kurzübersicht für FPR2 Antikörper (C-Term) (ABIN5540337)

Target: FPR2 (Formyl Peptide Receptor 2 (FPR2))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FPR2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)

Produktdetails anti-FPR2 Antikörper

Bindungsspezifität: C-Term

Sequenz: SASPPAETEL QAM

Spezifität: This antibody reacts with Human formyl peptide receptor-like 1.

Immunogen: A short peptide corresponding to the C-terminal amino acid sequence on FPRL1 was conjugated with KLH

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Buffer System: 0.01M PBS, pH 7.2

Konservierungsmittel: Azide free

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store lyophilized at 2-8°C for 6 month or at -20°C long term. After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Avoid repeated freezing and thawing. Shelf life: one year from despatch.

Haltbarkeit: 12 months

Details zu FPR2

Target: FPR2 (Formyl Peptide Receptor 2 (FPR2))

Andere Bezeichnung: fpr2,fprl1

Hintergrund: Human formyl peptide receptor-like 1(FPRL1) is a G-protein coupled seven transmembrane receptor. The receptor can bind to the formyl peptides derived from the degradation of the cell wall of infected bacteria and host cells. FPRL1 expressed on the cell surface of neutrophils and other leukocytes mediates the chemotaxis of these cells toward infected site. It has been reported that acute phase protein SAA is also a ligand of FPRL1 and SAA can induce the secretion of IL-8 and TNF-α by neutrophil through FPRL1 signalling. FPRL1 has also been shown to mediate the chemotaxis of microglia by Abeta42 peptide and the internalization of Abeta42 peptide into cytoplasma of macrophage, indicating that FRPL1 may participate in the Abeta42 peptide elicited pathogenesis in Alzheimer's disease.